Pharmaceutical package
Today the European Commission adopted a Communication and three legislative proposals with the overarching objective of ensuring that European citizens can increasingly benefit from a competitive industry that generates safe, innovative and accessible medicines.
The third legislative proposal aims at strengthening EU legislation to better protect EU citizens from the serious threats posed by fake medicines. There is an alarming increase of medicinal products detected in the EU which are false representations of authorised medicines. These products usually contain sub-standard or false ingredients, no ingredients or ingredients in the wrong dosage thus posing a serious threat to human health. The overall principle of the proposal adopted today by the European Commission is to protect the legal distribution chain from the infiltration of fake medicines. This will help to ensure confidence of distributors, health care professionals and patients in the medicinal products they trade, prescribe and purchase in the legal supply chain.
Press release, memo, voorstel, meer informatie.
Vzr. Rechtbank Amsterdam, 5 december 2008, KG ZA 08-1975 SR PvV, Reckitt Benkiser Healthcare B.V. tegen Unilever Nederland B.V. (met dank aan Madeleine de Cock Buning,
College van Beroep voor het bedrijfsleven, 16 september 2008, LJN: BG1604, Minister VWS tegen A B.V., te P.
Kamervragen met antwoord, nr. 20809000520. Antwoord van minister Verburg (Landbouw, Natuur en Voedselkwaliteit) (ontvangen 13 oktober 2008)
Reclame Code Commissie, 30 september 2008, dossier. 08.0425, Claessens tegen Q-Music Nederland B.V. (met dank aan Remco Klöters,